Evident Technologies Forms Quantum Dot Collaboration with NIST | GenomeWeb

NEW YORK, Aug. 24 (GenomeWeb News) - Evident Technologies said today that it has entered into a cooperative research and development agreement with the National Institute of Standards and Technology to investigate the use of quantum dot composite fluorescent standards for biotech instrumentation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.